UQCRB
protein-codingubiquinol-cytochrome c reductase binding protein, the group of Mitochondrial complex III: ubiquinol-cytochrome c reductase complex subunits
Gene summary
This gene encodes a subunit of the ubiquinol-cytochrome c oxidoreductase complex, which consists of one mitochondrial-encoded and 10 nuclear-encoded subunits. The protein encoded by this gene binds ubiquinone and participates in the transfer of electrons when ubiquinone is bound. This protein plays an important role in hypoxia-induced angiogenesis through mitochondrial reactive oxygen species-mediated signaling. Mutations in this gene are associated with mitochondrial complex III deficiency. Alternatively spliced transcript variants have been found for this gene. Related pseudogenes have been identified on chromosomes 1, 5 and X. [provided by RefSeq, Dec 2011]
- UQBP
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~12.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014064
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014064
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0044970
Submitter: ClinGen
The relationship between *UQCRB* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of October 7, 2024. The *UQCRB* gene encodes the ubiquinol-cytochrome *c* reductase binding protein, a component of the ubiquinol-cytochrome *c* oxidoreductase (complex III) that binds ubiquinone and participates in the transfer of electrons when ubiquinone is bound. The *UQCRB* gene was first reported in relation to autosomal recessive primary mitochondrial disease in 2003 (PMID: 12709789). *UQCRB* has been associated with a single disease entity to date; mitochondrial complex III deficiency, nuclear type 3 [OMIM# 615158]. This is one disease entity according to the ClinGen Lumping and Splitting Framework, and is considered a primary mitochondrial disease. Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included one homozygous frameshift variant identified in two unrelated cases from two publications (PMIDs: 12709789, 35221877). Features in the two reported individuals include metabolic acidosis, hypoglycemia, hepatomegaly, and elevated lactate. The mechanism of disease is suspected to be loss of function. This gene-disease relationship is also supported by a biochemical function shared with other genes associated with primary mitochondrial disease (PMID: 33340416). In summary, there is limited evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on October 7, 2024 (SOP Version 10).
Inheritance Pattern: AR
Disease ID:MONDO:0014064
Submitter: Ambry Genetics
Inheritance Pattern: Unknown
Disease ID:MONDO:0014064
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0015448
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Gastrointestinal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: Individuals may suffer acute episodes of metabolic crisis; Treatment with Mitochondrial cocktail type therapy may be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to UQCRB variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006294.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 1 | 7 | |||
| missense | 2 | 27 | 2 | 31 | ||
| nonsense | 1 | 1 | 2 | |||
| start loss | 1 | 1 | ||||
| frameshift | 1 | 1 | 1 | 3 | ||
| splice donor/acceptor (+/-2bp) | 4 | 4 | ||||
| Total | 1 | 5 | 33 | 8 | 1 | 48 |
Highest pathogenic variant AF is 0.00002231476
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_006285.1 | 4 | MANE Select | |
| Ensembl | ENSP00000287022.5 | 4 | MANE Select | |
| RefSeq | NP_001186904.1 | 2 | Standard | |
| RefSeq | NP_001241681.1 | 5 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| uqcrb | Danio rerio | Structure: angiogenic sprout Quality: decreased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Cardiac muscle contraction - Homo sapiens (human)
- Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human)
- Alzheimer,s disease - Homo sapiens (human)
- Huntington,s disease - Homo sapiens (human)
- Thermogenesis - Homo sapiens (human)
Biological Process
- oxidative phosphorylation
- mitochondrial electron transport, ubiquinol to cytochrome c
- aerobic respiration
- mitochondrial respiratory chain complex III assembly
- oxidation-reduction process
Molecular Function
- protein binding
- ubiquinol-cytochrome-c reductase activity
Cellular Component
- mitochondrial inner membrane
- mitochondrial respirasome
- mitochondrial respiratory chain complex III
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000518406
- Coding exons
- 5
- Length
- 9715
- Individuals with no LoFs
- 125718
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 10
- Defined
- 125728
- p
- 0.0000398
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.185 | 69 | 73.5 | 0.939 | 0.00000366 | 916 |
| Missense (PolyPhen) | 7 | 12.968 | 0.53978 | 189 | ||
| Synonymous | 0.154 | 23 | 24.0 | 0.960 | 0.00000114 | 239 |
| Loss of Function | 1.43 | 4 | 8.50 | 0.471 | 5.11e-7 | 93 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000070 | 0.000070 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: This is a component of the ubiquinol-cytochrome c reductase complex (complex III or cytochrome b-c1 complex), which is part of the mitochondrial respiratory chain. This component is involved in redox-linked proton pumping.;
- Disease
- DISEASE: Mitochondrial complex III deficiency, nuclear 3 (MC3DN3) [MIM:615158]: A disorder of the mitochondrial respiratory chain resulting in a highly variable phenotype depending on which tissues are affected. Clinical features include mitochondrial encephalopathy, psychomotor retardation, ataxia, severe failure to thrive, liver dysfunction, renal tubulopathy, muscle weakness and exercise intolerance. {ECO:0000269|PubMed:12709789}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.183
Intolerance Scores
- LoFtool
- 0.512
- RVIS EVS
- 0.15
- RVIS percentile EVS
- 64.11
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- H
- Indispensability pred.
- E
- Indispensability score
- 0.985
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |